Mn-metalloporphyrin conjugated with Gd-DTPA (Gd-ATN10): Tumor enhancement agent for magnetic resonance imaging

Neurologia Medico-Chirurgica

Volumn 37, Issue 4, 1997, Pages 327-331

  Matsumura, Akira ^a   Shibata, Yasushi ^a   Yamamoto, Tetsuya ^a   Nakagawa, Kunio ^a   Yasuda, Susumu ^a   Nakajima, Susumu ^b   Sakata, Isao ^c   Yoshizawa, Takashi ^a   Nose, Tadao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c Toyo Hakka Co Ltd   (Japan)

Author keywords

contrast enhancement; gadolinium; magnetic resonance imaging; metalloporphyrin; neutron capture therapy

Indexed keywords

GADOLINIUM PENTETATE DERIVATIVE; MANGANESE; METALLOPORPHYRIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DISTRIBUTION; GLIOSARCOMA; INTRAVENOUS DRUG ADMINISTRATION; NEUTRON CAPTURE THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; TISSUE DISTRIBUTION;

EID: 0030976262     PISSN: 03872572     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.37.327     Document Type: Article

References (14)

1. Akine Y, Tokita N, Tokuuye K, Satoh M, Fukumori Y, Tokumitsu H, Kanamori R, Kobayashi T, Kanda K: Neutron-capture therapy of murine ascites tumor with gadolinium containing micro capsules. J Cancer Res Clin Oncol 119: 71-73, 1992
2. Bockhorst K, Els T, Kohno K, Hoehn-Berlage M: Localization of experimental brain tumors in MRI by gadolinium porphyrin. Ada Neurochir Suppl (Wien) 60: 347-349, 1994
3. Furumanski P, Longley C: Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice. Cancer Res 48: 4604-4610, 1988
4. Hindre F, Le Plouzennec M, de Cartaines JD, Foultier MT, Patrice T, Simonneaux G: Tetra-p-aminophenylporphyrin conjugated with Gd-DTPA: Tumor-specific contrast agent for MR imaging. J Magn Reson Imaging 3: 59-65, 1993
5. Ikezaki K, Nomura T, Takahashi M, Zieroth BF, Fukui M: MRI contrast enhancement by Mn-TPPS in experimental rat brain tumor with peripheral benzodiazepine receptors. Acta Neurochir Suppl (Wien) 60: 353-355, 1994
6. Kasokat T, Urich K: Quantification of dechelation of gadopentate diglumine in rats. Arzneimitfelforschung 42: 869-876, 1992
7. Lyon RC, Faustino PJ, Cohen JS, Katz A, Mornex F, Colcher D, Baglin C, Koenig SH, Hambright P: Tissue distribution and stability of metalloporphyrin MRI contrast agents. Magn Reson Med 4: 24-33, 1987
8. Nakajima S, Hayashi H, Omote Y, Yamazaki Y, Hirata S, Maeda T, Takemura T, Kakiuchi Y, Shindo Y, Koshimizu K, Sakata I: The tumor-localizing properties of porphyrin derivatives. J Photochem Photobiol B 7: 189-198, 1990
9. 111In-labeled Mn-metalloporphyrin for tumor imaging. Nucl Med Biol 20: 231-237, 1993
10. Origitano TC, Karesh SM, Henkin RE, Halama JR, Reichman OH: Photo dynamic therapy for intracranial neoplasms: Investigations of photosensitizer uptake and distribution using indium-111 photofrin-II single photon emission computed tomography scans in humans with intracranial neoplasms. Neurosurgery 32: 357-364, 1993
11. Sakata I, Takada H, Ikeuchi M, Hirata N, Inui H, Nakajima S, Yamauchi H, Koshimizu K: Studies on porphyrin related compounds and tumor tissue affinities. Synthesis of a carrier for tumor imaging agent, bifunctional chelating agent coupled porphyrin (ATN-2). Yakugaku Zasshi 110: 916-921, 1990
12. Shih JLA, Brugger RM: Gadolinium as a neutron capture therapy agent. Med Phys 19: 733-744, 1992
13. Wedeking P, Kumar K, Tweedle MF: Dissociation of gadolinium chelates in mice: Relationship to chemical characteristics. Magn fleson Imaging 10: 611-618, 1992
14. Winkelman J: The distribution of tetraphenylporphine-sulfonate in the tumor bearing rat. Cancer Res 22: 589-596, 1962